Aspartylglucosaminuria
MONDO:0008830Aspartylglycosaminuria (AGU) is an autosomal recessive lysosomal storage disease belonging to the oligosaccharidosis group (also called glycoproteinosis).
Also known as: Aspartylglycosaminuria, aspartylglucosaminidase deficiency, aspartylglucosaminuria, aspartylglycosaminuria, glycosylasparaginase deficiency, AGU, Aga deficiency, Aspartylglucosamidase (AGA) deficiency
4 clinical trials for this condition and its sub-types, 4 tagged with Aspartylglucosaminuria itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New stem cell approach aims to tame rare genetic diseases
Disease control OngoingThis study tests a stem cell transplant method for people with inherited metabolic disorders and severe osteopetrosis. The goal is to get the donor cells to take hold while keeping side effects low. Participants receive chemotherapy drugs before the transplant to prepare their bo…
Phase 2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Cervical cancer screening showdown: pap vs. blood test study pulled
Diagnosis CancelledThis study was designed to compare the standard Pap smear with a new blood test that looks for three proteins linked to cervical cell changes. It planned to include adults aged 18-85 in good health. However, the study was withdrawn before enrolling any participants, so no results…
Sponsor: Timser SAPI de CV • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC